As part of CASEL’s special series highlighting work in the priority area of respiratory health outcomes and nicotine/tobacco use, we bring your attention to a Special Issue, Respiratory Disease and Nicotine/Tobacco Use, that was just published open access in Nicotine & Tobacco Research.

Recent and rapidly arising critical health events, such as EVALI and the SARS CoV-2 pandemic, highlight the importance of examining how tobacco and nicotine products may influence and interact with respiratory health. This Special Issue on respiratory disease associations with cigarettes and non-cigarette nicotine and tobacco use includes a collection of multidisciplinary studies that begin to examine the effect of tobacco and nicotine use from the cellular level to patterns of use and symptomology at the population level. Please check out the issue or download any of the 13 papers here:  https://academic.oup.com/ntr/issue/22/Supplement_1

A Special Issue, Patterns of Tobacco Product Use in the United States: Transitions across Three Waves of the PATH Study (2013-2016), has been published in Tobacco Control. This Special Issue, a collaboration between NIDA, FDA, CDC, Westat and Roswell Park Comprehensive Cancer Center, examines tobacco transition behaviors and correlates of these behaviors using data from the NIH and FDA supported Population Assessment of Tobacco and Health (PATH) Study, a U.S. nationally representative longitudinal tobacco study of about 46,000 persons aged 12+ years. The issue includes a series of peer-reviewed papers, each focused on a tobacco product (cigarette, e-cigarette, hookah, cigar, and smokeless) and examining 3-wave longitudinal pathways of exclusive and poly- tobacco product use for youth, young adults, and adults 25 years or older. Longitudinal three-wave pathways of exclusive and poly- tobacco initiation among baseline never users are also featured, with exploration of common pathways for new initiators of e-cigarettes and cigarettes. Moreover, three papers in the issue use weighted generalized estimating equations to evaluate correlates of tobacco product initiation, cessation, and relapse. Please check out the issue or download any of the 11 papers here:

https://tobaccocontrol.bmj.com/content/29/Suppl_3 

The need for evidence to guide the FDA into best evidence-based strategies to limit the spread of waterpipe use among young people and harm to public health was the rationale for NIH’s issuance of an R01 program to address the “Chemistry, Toxicology, and Addiction Research on Waterpipe Tobacco.”  The collective research projects aimed to address the biomedical, behavioral and social science research to inform regulatory action on waterpipe tobacco products.  Nine research teams were funded under this program and comprised the Waterpipe Tobacco Special Interest Group; their findings are presented in this special issue.

The papers in this Special Issue showcase the measurement collection in the PhenX Toolkit that were established for use in tobacco regulatory research, and will provide investigators a better understanding as to the purpose and scope of project. It also allows investigators to cite support for their use of the measures in grant applications and publications. Hopefully, it will provide a foundation for their engagement in determining the content for future updates to the collections, as well. 

The content is free to read and download, with no access controls:  https://tobaccocontrol.bmj.com/content/29/Suppl_1